Holen Sie sich die Stockscreener-App
85.77
4.06%
-4.4817
Schlusskurs vom Vortag:
$90.25
Offen:
$89.84
24-Stunden-Volumen:
597.77K
Relative Volume:
1.16
Marktkapitalisierung:
$4.75B
Einnahmen:
$76.81M
Nettoeinkommen (Verlust:
$-162.42M
KGV:
-28.69
EPS:
-2.99
Netto-Cashflow:
$-122.49M
1W Leistung:
-0.13%
1M Leistung:
+1.78%
6M Leistung:
+32.09%
1J Leistung:
+0.48%
1-Tages-Spanne:
$84.55
$92.34
1-Wochen-Bereich:
$84.55
$92.34
52-Wochen-Spanne:
$47.86
$107.37
Arcellx Inc Stock (ACLX) Company Profile
Firmenname
Arcellx Inc
Sektor
Branche
Telefon
240-327-0603
Adresse
800 BRIDGE PARKWAY, REDWOOD CITY
Vergleichen Sie ACLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
85.73 | 5.01B | 76.81M | -162.42M | -122.49M | -2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.48 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
639.93 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.94 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.90 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.96 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | Stifel | Buy |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2024-10-08 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-10-30 | Eingeleitet | TD Cowen | Outperform |
| 2023-10-17 | Eingeleitet | UBS | Buy |
| 2023-05-18 | Eingeleitet | Truist | Buy |
| 2023-04-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-14 | Eingeleitet | Stifel | Buy |
| 2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-13 | Fortgesetzt | BofA Securities | Buy |
| 2022-10-31 | Eingeleitet | Guggenheim | Buy |
| 2022-10-27 | Eingeleitet | Needham | Buy |
| 2022-07-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-03-01 | Eingeleitet | BofA Securities | Buy |
| 2022-03-01 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Arcellx Inc Aktie (ACLX) Neueste Nachrichten
Arcellx (ACLX): Canaccord Genuity Raises Price Target to $130 | - GuruFocus
Arcellx (NASDAQ: ACLX) to present iMMagine-1 update at ASH; pre-BLA completed - Stock Titan
Canaccord Genuity raises Arcellx stock price target on higher anito-cel launch revenue By Investing.com - Investing.com Nigeria
Canaccord Genuity raises Arcellx stock price target on higher anito-cel launch revenue - Investing.com
Tools to assess Arcellx Inc.’s risk profileWeekly Trade Report & Capital Efficient Trading Techniques - newser.com
Can technical indicators confirm Arcellx Inc.’s reversal2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Is Arcellx Inc. stock a dividend growth opportunityWatch List & Long Hold Capital Preservation Plans - newser.com
How Arcellx Inc. stock performs during Fed tightening cyclesBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Risk vs reward if holding onto Arcellx Inc.2025 Price Targets & Low Drawdown Investment Strategies - newser.com
What institutional flow reveals about Arcellx Inc.Market Volume Summary & Smart Investment Allocation Insights - newser.com
Arcellx, Inc. $ACLX Shares Sold by Pier Capital LLC - MarketBeat
Signal strength of Arcellx Inc. stock in tech scannersWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com
Trend analysis for Arcellx Inc. this weekOil Prices & Verified Technical Signals - newser.com
Fresh Analyst Optimism on CAR T-Cell Advances Might Change the Case for Investing in Arcellx (ACLX) - simplywall.st
Will Arcellx Inc. stock split again soon2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Arcellx (ACLX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Using Python tools to backtest Arcellx Inc. strategiesJuly 2025 Short Interest & AI Optimized Trade Strategies - newser.com
Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Is Arcellx Inc. stock a buy for dividend growthJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
Arcellx Insiders Sell US$3.9m Of Stock, Possibly Signalling Caution - 富途牛牛
Canaccord Genuity Sticks to Their Buy Rating for Arcellx Inc (ACLX) - The Globe and Mail
Arcellx’s iMMagine-3 Study: A Potential Game-Changer for Multiple Myeloma Treatment - TipRanks
What drives Arcellx Inc stock priceEnergy Sector Updates & Minimal Capital Growth Ideas - earlytimes.in
Will Arcellx Inc. stock benefit from green energy trendsPortfolio Value Summary & Risk Controlled Stock Alerts - fcp.pa.gov.br
Arcellx Advances in Autoimmune Treatment with Anitocabtagene Autoleucel Study - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Finanzdaten der Arcellx Inc-Aktie (ACLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):